Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 May;63(5):804–808. doi: 10.1038/bjc.1991.178

Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study.

K Ebeling 1, R Ray 1, P Nischan 1, D B Thomas 1, D Kunde 1, H Stalsberg 1
PMCID: PMC1972388  PMID: 1710136

Abstract

The main subject of this hospital-based case-control study was the possible relationship between use of combined oral contraceptives (OCs) containing chlormadinone acetate and breast cancer. Analyses were based on data from 490 cases with newly diagnosed breast cancer and 1,223 controls and were separately performed for combined OCs with and without chlormadinone. For either of the combined OCs, risk was not elevated in ever users, did not increase with duration of use and did not change with time since initial exposure or with time since most recent use. However, the relative risk was increased in current users: RR = 1.72 (0.88, 3.36) for combined OCs with chlormadinone and RR = 1.42 (1.01, 2.00) for combined OCs without chlormadinone, which is, however, explained as a screening effect. These results show that chlormadinone as a constituent of combined OCs does not influence breast cancer risk.

Full text

PDF
804

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinton L. A., Hoover R., Szklo M., Fraumeni J. F., Jr Oral contraceptives and breast cancer. Int J Epidemiol. 1982 Dec;11(4):316–322. doi: 10.1093/ije/11.4.316. [DOI] [PubMed] [Google Scholar]
  2. Diczfalusy E. Gregory Pincus and steroidal contraception revisited. Acta Obstet Gynecol Scand Suppl. 1982;105:7–15. doi: 10.3109/00016348209155312. [DOI] [PubMed] [Google Scholar]
  3. El Etreby M. F., Gräf K. J., Beier S., Elger W., Günzel P., Neumann F. Suitability of the beagle dog as a test model for the tumorigenic potential of contraceptive steroids. "A short review". Contraception. 1979 Sep;20(3):237–256. doi: 10.1016/0010-7824(79)90096-9. [DOI] [PubMed] [Google Scholar]
  4. Ellery C., MacLennan R., Berry G., Shearman R. P. A case-control study of breast cancer in relation to the use of steroid contraceptive agents. Med J Aust. 1986 Feb 17;144(4):173–176. doi: 10.5694/j.1326-5377.1986.tb128351.x. [DOI] [PubMed] [Google Scholar]
  5. Giles R. C., Kwapien R. P., Geil R. G., Casey H. W. Mammary nodules in beagle dogs administered investigational oral contraceptive steroids. J Natl Cancer Inst. 1978 Jun;60(6):1351–1364. doi: 10.1093/jnci/60.6.1351. [DOI] [PubMed] [Google Scholar]
  6. Kloskowski S., Ebeling K. Zum Nutzen der jährlichen ärztlichen Untersuchung der Brust für die Früherkennung des Mammakarzinoms. Z Arztl Fortbild (Jena) 1990;84(9):453–457. [PubMed] [Google Scholar]
  7. Kwapien R. P., Giles R. C., Geil R. G., Casey H. W. Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids. J Natl Cancer Inst. 1980 Jul;65(1):137–144. [PubMed] [Google Scholar]
  8. La Vecchia C., Decarli A., Fasoli M., Franceschi S., Gentile A., Negri E., Parazzini F., Tognoni G. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. Br J Cancer. 1986 Aug;54(2):311–317. doi: 10.1038/bjc.1986.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McPherson K., Vessey M. P., Neil A., Doll R., Jones L., Roberts M. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer. 1987 Nov;56(5):653–660. doi: 10.1038/bjc.1987.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nelson L. W., Carlton W. W., Weikel J. H., Jr Canine mammary neoplasms and progestogens. JAMA. 1972 Mar 20;219(12):1601–1606. [PubMed] [Google Scholar]
  11. Nelson L. W., Kelly W. A. Progestogen-related gross and microscopic changes in female Beagles. Vet Pathol. 1976;13(2):143–156. doi: 10.1177/030098587601300209. [DOI] [PubMed] [Google Scholar]
  12. Nelson L. W., Weikel J. H., Jr, Reno F. E. Mammary nodules in dogs during four years' treatment with megestrol acetate or chlormadinone acetate. J Natl Cancer Inst. 1973 Oct;51(4):1303–1311. doi: 10.1093/jnci/51.4.1303. [DOI] [PubMed] [Google Scholar]
  13. Nischan P., Ebeling K. Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic--a correlation analysis. Int J Cancer. 1984 Nov 15;34(5):671–674. doi: 10.1002/ijc.2910340514. [DOI] [PubMed] [Google Scholar]
  14. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  15. Prentice R. L., Thomas D. B. On the epidemiology of oral contraceptives and disease. Adv Cancer Res. 1987;49:285–401. doi: 10.1016/s0065-230x(08)60801-5. [DOI] [PubMed] [Google Scholar]
  16. Rosenberg L., Miller D. R., Kaufman D. W., Helmrich S. P., Stolley P. D., Schottenfeld D., Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol. 1984 Feb;119(2):167–176. doi: 10.1093/oxfordjournals.aje.a113735. [DOI] [PubMed] [Google Scholar]
  17. Schlesselman J. J., Stadel B. V., Murray P., Lai S. Breast cancer in relation to early use of oral contraceptives. No evidence of a latent effect. JAMA. 1988 Mar 25;259(12):1828–1833. [PubMed] [Google Scholar]
  18. Vallance D. K., Capel-Edwards K. Chlormadinone and mammary nodules. Br Med J. 1971 Apr 24;2(5755):221–222. doi: 10.1136/bmj.2.5755.221-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES